🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HBeAg-negative chronic hepatitis B (CHB) patients with low Level HBsAg were...
Status
Unknown
Location
Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University
Start Date
2019-01-01
Trial ID
NCT03801538
Treatments Being Tested
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
The study evaluates safety and efficacy of vaniprevir (MK7009), when admini...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-20
Trial ID
NCT00880763
Treatments Being Tested
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
The goal of this clinical research study is to learn if adding pegylated in...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-10
Trial ID
NCT01392170
Treatments Being Tested
The current study is a prospective, randomized, open, multi-center investig...
Status
Unknown
Location
Xixi Hospital of Hangzhou
Start Date
2016-11
Trial ID
NCT03013556
Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Status
Unknown
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01001754
Treatments Being Tested
This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Status
Completed
Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Start Date
2015-01
Trial ID
NCT02480686
Treatments Being Tested
This study is to evaluate the overall efficacy, and safety profile of the t...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01500772
Treatments Being Tested
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380